Allied Market Research

Hospital-Acquired Infection Diagnostics Market Global Briefing 2017 to 2022

The hospital-acquired infection diagnostics market is segmented based on product, test type, application, infection type, end user, and region.


Portland, OR -- (SBWIRE) -- 11/09/2017 -- According to a new report published by Allied Market Research, titled, Hospital-acquired infection diagnostics Market by Product, Test Type, Application, Infection Type and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global hospital-acquired infection diagnostics market was valued at $2,571 million in 2016, and is projected to reach $4,311 million by 2023, growing at a CAGR of 7.5% from 2017 to 2023. The urinary tract infections (UTI) segment accounted for maximum share of the total market in 2016.

Hospital-acquired infection are contaminations caused by bacteria, viral, and fungal pathogens. These infections are usually acquired in clinical and hospital settings mainly due to an infected patient, outside environment, or from the staff of that facility.

Get the sample copy of this report:

Rise in prevalence of infections from hospitals and clinical settings drive the market. However, the lack of awareness regarding hospital-acquired infection diagnostics impedes the market growth. Moreover, the technological advancements in healthcare sector for the innovation of novel and sophisticated products is projected to create lucrative opportunities for key market players.

Make a purchase enquiry:

Drug resistance testing segment is anticipated to maintain its dominance during the forecast period, accounting for major share of the global hospital-acquired infections diagnostics market. This is due to the benefits drug resistance testing offers such as they are cost-effective when the prevalence of drug resistance in chronically infected patients is low.

Hospital-acquired Infection Diagnostics Market key Segments:

By Product

-Instrument & Reagents

By Test Type

-Molecular Diagnostics

By Application

-Disease Testing
-Drug-Resistance Testing

By Infection Type

-Hospital Acquired Pneumonia
-Bloodstream Infections
-Surgical Site Infections
-Gastrointestinal Infections
-Urinary Tract Infections (UTI)

End User

-Ambulatory Surgery Centers (ASC)